Acta Paediatrica: Vol 113, No 5
Click on the title to browse this issue
Click on the title to browse this issue
The Permanente Medical Group’s focused strategy to cut physician burnout is earning national recognition. Learn more with the AMA.
Led by California, a few states are testing an experimental program that pays people to stop using hard drugs. The Golden State was the first…
Physician discusses recent study findings that cardiac biomarkers will not likely help risk-stratify patients.
Ageing-related diseases (ARDs) exhibit a broad spectrum of phenotypes yet consistently increase in incidence with advancing age. This suggests that, despite their diversity, ARDs could…
Japan’s Otsuka Pharmaceutical said on Wednesday it would stop developing an experimental drug to treat agitation and restlessness caused by symptoms of Alzheimer’s disease.
Mousedouble minute 2 (MDM2) is one of the molecules activated by p53 and plays an important role in the regulation of p53. MDM2 is generally…
Prime minister gambles by triggering vote when polls suggest heavy defeat
In this Viewpoint, Donald Berwick explores the pursuit of profit in US health care across sectors—such as pharmaceutical companies, insurers, hospitals, and physician practices—and its…
The Harvard Medical School Master’s Graduation Ceremony for the Class of 2024 will take place Wednesday, May 22. During the ceremony, graduating students are…
Researchers have found that a newly developed modified sugar increases the efficacy and safety of antisense oligonucleotides designed to treat central nervous system disease.